Mario Poljak

43PUBLICATIONS
81CO-AUTHORS
Predictive and prognostic markersCancer diagnosisObstetrics and gynaecologyPreventative health careMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Oct 13, 2026
The Role of Methylation Marker FAM19A4/mir124-2 and HPV Genotype in Active Surveillance of Women With Cervical Intraepithelial Neoplasia Grade 2 (CIN2).

|Apr 25, 2026
International Collaborative Study on Human Papillomavirus Analytical Thresholds for Sensitivity and Specificity in Cervical Screening.

|Feb 18, 2026
Bacterial microbiome analysis of vaginal, cervical, and endometrial samples in patients with adenomyosis during the window of implantation.

Nika Troha, Tomaž M Zorec, Lea Hošnjak

|Oct 28, 2025
Prevalence of High-Risk Human Papillomaviruses (HPV) in Slovenian Women Attending Organized National Cervical Cancer Screening 14 Years After Implementation of the National HPV Vaccination Program.

Mateja Lasič, Anja Oštrbenk, Špela Smrkolj

|Nov 14, 2024
Long-Term Infection With a Particular Human Papillomavirus (HPV) Genotype, HPV Subtype, or HPV Genomic Variant Does not Significantly Influence the Clinical Course of Recurrent Respiratory Papillomatosis.

Daša Gluvajić, Lea Hošnjak, Tomaž Mark Zorec

|Sep 02, 2024
Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screening.

Marc Arbyn, Kate Cuschieri, Jesper Bonde

Pageof 8

Frequent Collaborators

9 joint publications

Lea Hošnjak

8 joint publications

Tomaž Mark Zorec

3 joint publications

Lan Xu

3 joint publications

Daniëlle A M Heideman